Impact of graft‐versus‐host disease prophylaxis strategies on <scp>GvHD</scp> ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis
Year: 2025
Type: article
Language: en
Topic: Hematopoietic Stem Cell Transplantation
Authors and affiliations:
raw_author_name: Nihar Desai
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Sergio Rodriguez Rodriguez
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
raw_author_name: Eshrak Al‐Shaibani
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Tommy Alfaro Moya
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Igor Novitzky‐Basso
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
raw_author_name: Arjun Datt Law
raw_affiliation_strings: Department of Medicine University of Toronto  Toronto Ontario Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology Princess Margaret Cancer Centre  Toronto Ontario Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada